TriSalus Life Sciences (TLSI) Inventory Average (2023 - 2026)

TriSalus Life Sciences (TLSI) has 4 years of Inventory Average data on file, last reported at $3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 16.5% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (down 16.5% YoY), and the FY2025 full-year result was $3.6 million, up 8.07% from the prior year.
• Inventory Average for Q1 2026 stood at $3.4 million, up from $3.2 million in the prior quarter.
• Across five years, Inventory Average topped out at $4.1 million in Q1 2025 and bottomed at $2.1 million in Q4 2023.
• The 4-year median for Inventory Average is $3.5 million (2025), against an average of $3.4 million.
• The widest annual swing landed in 2024, when Inventory Average surged 92.79%; it then declined 21.05% in 2025.
• A 4-year view of Inventory Average shows it stood at $2.1 million in 2023, then surged by 92.79% to $4.0 million in 2024, then slipped by 21.05% to $3.2 million in 2025, then increased by 7.9% to $3.4 million in 2026.
• The last three Inventory Average figures came in at $3.4 million (Q1 2026), $3.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.

Peer Comparison